» Articles » PMID: 34571760

Multiple Introductions of Rabbit Hemorrhagic Disease Virus /GI.2 in Africa

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2021 Sep 28
PMID 34571760
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rabbit hemorrhagic disease (RHD) causes high mortality and morbidity in European rabbits (). In Africa, the presence of the causative agent, the rabbit hemorrhagic disease virus (RHDV), was first confirmed in 1992 (genotype /GI.1). In 2015, the new genotype /GI.2 (RHDV2/b) was detected in Tunisia. Currently, GI.2 strains are present in several North and Sub-Saharan African countries. Considerable economic losses have been observed in industrial and traditional African rabbitries due to RHDV. Like other RNA viruses, this virus presents high recombination rates, with the emergence of GI.2 being associated with a recombinant strain. Recombination events have been detected with both pathogenic (GI.1b and GII.1) and benign (GI.3 and GI.4) strains. We obtained complete genome sequences of Tunisian GI.2 strains collected between 2018 and 2020 and carried out phylogenetic analyses. The results revealed that Tunisian strains are GI.3P-GI.2 strains that were most likely introduced from Europe. In addition, the results support the occurrence of multiple introductions of GI.2 into Africa, stressing the need for characterizing complete genome sequences of the circulating lagoviruses to uncover their origin. Continued monitoring and control of rabbit trade will grant a better containment of the disease and reduce the disease-associated economic losses.

Citing Articles

Two decades of occurrence of non-pathogenic rabbit lagoviruses in Italy and their genomic characterization.

Cavadini P, Patrizia C, Vismarra A, Merzoni F, Di Giovanni V, Boniotti M Sci Rep. 2024; 14(1):29234.

PMID: 39587141 PMC: 11589700. DOI: 10.1038/s41598-024-79670-y.


Rabbit hemorrhagic disease virus 2, 2010-2023: a review of global detections and affected species.

Asin J, Calvete C, Uzal F, Crossley B, Duarte M, Henderson E J Vet Diagn Invest. 2024; 36(5):617-637.

PMID: 39344909 PMC: 11457751. DOI: 10.1177/10406387241260281.


Characterisation of GI-RHDVs (Rabbit Haemorrhagic Disease Viruses) in Terms of Their Pathogenicity and Immunogenicity.

Tokarz-Deptula B, Kulus J, Baraniecki L, Stosik M, Deptula W Int J Mol Sci. 2024; 25(10).

PMID: 38791380 PMC: 11120834. DOI: 10.3390/ijms25105342.


Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits.

Bosco-Lauth A, Schueler A, Midthun E, Tyra H, Held A, Hood C Viruses. 2024; 16(4).

PMID: 38675881 PMC: 11054048. DOI: 10.3390/v16040538.


Epidemiological characterization and risk assessment of rabbit haemorrhagic disease virus 2 (RHDV2/b/GI.2) in the world.

Sun Z, An Q, Li Y, Gao X, Wang H Vet Res. 2024; 55(1):38.

PMID: 38532494 PMC: 10967181. DOI: 10.1186/s13567-024-01286-x.


References
1.
Lopes A, Rouco C, Esteves P, Abrantes J . GI.1b/GI.1b/GI.2 recombinant rabbit hemorrhagic disease virus 2 (Lagovirus europaeus/GI.2) in Morocco, Africa. Arch Virol. 2018; 164(1):279-283. DOI: 10.1007/s00705-018-4052-y. View

2.
Erfan A, Shalaby A . Genotyping of rabbit hemorrhagic disease virus detected in diseased rabbits in Egyptian Provinces by sequencing. Vet World. 2020; 13(6):1098-1107. PMC: 7396351. DOI: 10.14202/vetworld.2020.1098-1107. View

3.
Bouslama A, De Mia G, Hammami S, Aouina T, Soussi H, FRESCURA T . Identification of the virus of rabbit haemorrhagic disease in Tunisia. Vet Rec. 1996; 138(5):108-10. DOI: 10.1136/vr.138.5.108. View

4.
Szillat K, Hoper D, Beer M, Konig P . Full-genome sequencing of German rabbit haemorrhagic disease virus uncovers recombination between RHDV (GI.2) and EBHSV (GII.1). Virus Evol. 2020; 6(2):veaa080. PMC: 7724246. DOI: 10.1093/ve/veaa080. View

5.
Rahali N, Sghaier S, Kbaier H, Zanati A, Bahloul C . Genetic characterization and phylogenetic analysis of rabbit hemorrhagic disease virus isolated in Tunisia from 2015 to 2018. Arch Virol. 2019; 164(9):2327-2332. DOI: 10.1007/s00705-019-04311-z. View